Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV-2 infections

The coronavirus disease 2019 (COVID-19) has caused global public health and economic crises. Thus, new therapeutic strategies and effective vaccines are urgently needed to cope with this severe pandemic. The development of a broadly neutralizing antibody against severe acute respiratory syndrome cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Rongtao, Zhou, Tianhui, Xiang, Xiaogang, Lu, Jie, Xin, Haiguang, Xie, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2021
Materias:
Letter to Frontiers of Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079842/
https://www.ncbi.nlm.nih.gov/pubmed/33909259
http://dx.doi.org/10.1007/s11684-021-0847-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079842/
https://www.ncbi.nlm.nih.gov/pubmed/33909259
http://dx.doi.org/10.1007/s11684-021-0847-4

Ejemplares similares